Fundz

Mitorx Therapeutics Announces Seed Financing To Advance Its Mitochondrial-Protective Therapeutics To Treat Degenerative Diseases

PRIVATEApr 25, 2022

Round Type

Seed

OxfordBiotechnologyHealth CareTherapeutics

Description

MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed.

Who to call at MitoRx Therapeutics, and when

A new round usually means MitoRx Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MitoRx Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MitoRx Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MitoRx Therapeutics. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MitoRx Therapeutics

Location

Oxford, England, United Kingdom

About

MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MitoRx Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for MitoRx Therapeutics's next move

See what Strategic adds

MitoRx Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.